Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Manzoni P et al. | Prevention strategies in patients at high-risk for Candida infections: data from a neonatal intensive care setting. | 2006 | Intensive Care Med | pmid:16601958 |
| Normand S et al. | Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. | 2005 | Intensive Care Med | pmid:16195905 |
| Eggimann P et al. | Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? | 2005 | Intensive Care Med | pmid:16195906 |
| Holý R and Pozivil J | Batch control system project for a pharmaceutical plant. | 2002 | ISA Trans | pmid:12071257 |
| Dalben-Dota KF et al. | Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. | 2010 | J Altern Complement Med | pmid:20192913 |
| Lewith GT et al. | Elevation of Candida IgG antibodies in patients with medically unexplained symptoms. | 2007 | J Altern Complement Med | pmid:18166126 |
| Muñante-Cárdenas JL et al. | Treating oral histoplasmosis in an immunocompetent patient. | 2009 | J Am Dent Assoc | pmid:19884394 |
| Goebel WM and Duquette P | Mycotic infections associated with complete dentures: report of three cases. | 1974 | J Am Dent Assoc | pmid:4521776 |
| Glick M and Muzyka BC | Alternative therapies for major aphthous ulcers in AIDS patients. | 1992 | J Am Dent Assoc | pmid:1619168 |
| SENECA H | CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM. | 1964 | J Am Geriatr Soc | pmid:14229964 |
| Peacock G et al. | Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. | 2010 Jan-Feb | J Am Pharm Assoc (2003) | pmid:20097644 |
| Hemmateenejad B et al. | Photodegradation study of nystatin by UV-Vis spectrophotometry and chemometrics modeling. | 2014 Jul-Aug | J AOAC Int | pmid:25145159 |
| Alcântara CS et al. | Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. | 2012 Nov-Dec | J Appl Oral Sci | pmid:23329241 |
| Lima JF et al. | Porosity of temporary denture soft liners containing antifungal agents. | 2016 Sep-Oct | J Appl Oral Sci | pmid:27812615 |
| Ellepola AN et al. | Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. | 2015 Jul-Aug | J Appl Oral Sci | pmid:26398514 |
| Holder IA and Neely AN | Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? Assessment by two topical antimicrobial test assay systems. | 2001 Jul-Aug | J Burn Care Rehabil | pmid:11482688 |
| Levenson C et al. | Preventing postoperative burn wound aspergillosis. | 1991 Mar-Apr | J Burn Care Rehabil | pmid:2050719 |
| Sheridan RL et al. | Candidemia in the pediatric patient with burns. | 1995 Jul-Aug | J Burn Care Rehabil | pmid:8582925 |
| Stoopler ET | Management of oral chronic graft-versus-host disease. | 2013 | J Can Dent Assoc | pmid:23763728 |
| Sauer B and Matusch R | High-performance liquid chromatographic separations of nystatin and their influence on the antifungal activity. | 1994 | J Chromatogr A | pmid:8069397 |
| Heneedak HM et al. | HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. | 2012 Nov-Dec | J Chromatogr Sci | pmid:22879356 |
| Kovac M et al. | Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. | 2012 | J Clin Pharm Ther | pmid:21332566 |
| Croy SR and Kwon GS | The effects of Pluronic block copolymers on the aggregation state of nystatin. | 2004 | J Control Release | pmid:14980765 |
| Aksungur P et al. | Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. | 2004 | J Control Release | pmid:15262418 |
| Khan MA et al. | Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model. | 2006 | J Drug Target | pmid:16777682 |
| Khan MA et al. | Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. | 2003 | J Drug Target | pmid:12881195 |
| Khan MA et al. | Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice. | 2004 | J Drug Target | pmid:15621667 |
| DeYoung M | Treatment of a yeast infection in one ileostomy patient. | 1982 May-Jun | J Enterostomal Ther | pmid:6918412 |
| Tzatzarakis MN et al. | Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. | 2001 | J Environ Sci Health B | pmid:11411855 |
| Kandile NG and Zaky HT | New pyrano[2,3-c]pyridazine derivatives with antimicrobial activity synthesized using piperidine as the organocatalyst. | 2015 | J Enzyme Inhib Med Chem | pmid:24666292 |
| Carvalho JC et al. | Anti-inflammatory activity of the crude extract from the fruits of Pterodon emarginatus Vog. | 1999 | J Ethnopharmacol | pmid:10197747 |
| Wu D et al. | Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa. | 2011 | J Ethnopharmacol | pmid:21195154 |
| Kuete V et al. | Antimicrobial activity of the methanolic extracts and compounds from Treculia obovoidea (Moraceae). | 2007 | J Ethnopharmacol | pmid:17532157 |
| Su CW et al. | Clinical inquiries. What is the best treatment for oral thrush in healthy infants? | 2008 | J Fam Pract | pmid:18625176 |
| Noss MR and Cha J | Erythematous penile lesion. | 2012 | J Fam Pract | pmid:23313994 |
| Skinner N et al. | Clinical inquiries. What is angular cheilitis and how is it treated? | 2005 | J Fam Pract | pmid:15865910 |
| King K | Prophylactic non-absorbable antibiotics in leukaemic patients. | 1980 | J Hyg (Lond) | pmid:7052229 |
| Vural A et al. | The Effect of Nystatin Solution on Otoacoustic Emissions in Rats. | 2017 | J Int Adv Otol | pmid:27819649 |
| de la Borbolla JM et al. | Late reaction to oral nystatin: the importance of patch testing. | 2009 | J Investig Allergol Clin Immunol | pmid:19639730 |
| Ellepola AN et al. | Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka. | 2016 | J Investig Clin Dent | pmid:26059506 |
| Ellepola AN et al. | Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. | 2016 | J Investig Clin Dent | pmid:25388637 |
| Nakhla V et al. | Myringoplasty: a comparison of bismuth iodoform paraffin paste gauze pack and tri-adcortyl ointment ear dressing. | 2007 | J Laryngol Otol | pmid:17105678 |
| Doshi J et al. | Observational study of bone-anchored hearing aid infection rates using different post-operative dressings. | 2006 | J Laryngol Otol | pmid:16709268 |
| Padilha MM et al. | Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). | 2009 | J Med Food | pmid:19459738 |
| Santos KK et al. | Anti-Candida activity of Mentha arvensis and Turnera ulmifolia. | 2012 | J Med Food | pmid:22082100 |
| Bulacio L et al. | Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. | 2012 | J Mycol Med | pmid:23518170 |
| El-Wahidi M et al. | [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. | 2013 | J Mycol Med | pmid:23726234 |
| Semis R et al. | Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. | 2015 | J Mycol Med | pmid:25639922 |
| Mansourian A et al. | The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. | 2014 | J Mycol Med | pmid:25442923 |
| Choukri F et al. | In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. | 2014 | J Mycol Med | pmid:25442913 |